The Multiple Sclerosis Association of America Launches Online Support Community for Individuals Affected by MS

The Multiple Sclerosis Association of America (MSAA) announces the official launch of My MSAA Community. Powered by HealthUnlocked, this new online community forum has been created to offer people living with multiple sclerosis (MS), care partners, and family members a way to connect with others going through the same challenges as well as receive valuable […]

Read News Article

Highlights from the AAN and CMSC Annual Meetings

Two vital conferences providing the latest information and research on multiple sclerosis (MS) take place in the spring of each year. These are the American Academy of Neurology (AAN) and The Consortium of Multiple Sclerosis Centers (CMSC) Annual Meetings. The 68th Annual Meeting of the AAN took place April 15-21, 2016, in Vancouver, Canada. More […]

Read News Article

My MS Manager Named One of the Best MS Apps of 2016

My MS Manager™, MSAA’s free mobile phone app, has been recognized by Healthline.com as one of the best multiple sclerosis (MS) apps for the fourth consecutive year. Healthline editors selected this year’s winners based on user ratings, frequent updates, and overall impact in making a valuable contribution to the lives of people in the MS […]

Read News Article

FDA Accepts Review of Application for Ocrelizumab

On June 27, 2016, Genentech, a member of the Roche group, announced that the Biologics License Application (BLA) for ocrelizumab has been accepted for review by the United States Food and Drug Administration (FDA). This is the first time that an investigational medication is being reviewed for the treatment of two types of multiple sclerosis […]

Read News Article

Eligible People with PPMS May Receive Experimental Medication

Ocrelizumab, an experimental medication presently under investigation for the treatment of primary-progressive multiple sclerosis (PPMS), will be available for eligible individuals with PPMS through an Expanded Access Program (EAP). An EAP enables participants to receive an investigational medication that has not yet been approved by the United States Food and Drug Administration (FDA). This program […]

Read News Article

MSAA Wins APEX 2016 Awards for Publication Excellence

MSAA has been awarded the APEX 2016 Grand Award in the category of Writing for the cover story, “Cognitive Issues with Multiple Sclerosis: Research, Strategies, and Support,” featured in the Winter/Spring 2015 issue of our national magazine, The Motivator. The Grand Award is the highest recognition from APEX. With more than 1,600 entries from around […]

Read News Article

The Multiple Sclerosis Association of America Publishes New Resources

The Multiple Sclerosis Association of America (MSAA) is pleased to announce three newly published resources for the multiple sclerosis (MS) community. The new resources are available free-of-charge as both printed and online publications at mymsaa.org. MSAA’s award-winning magazine, The Motivator, provides valuable information and support for individuals living with MS, their care partners, family members, […]

Read News Article

MS Conversations Recognized as Top MS Blog of 2016 by Healthline.com

MSAA’s MS Conversations blog is honored to be named one of 2016’s best multiple sclerosis blogs by Healthline.com. Healthline recently chose 23 blogs that actively work to educate, inspire, and empower readers with frequent updates and high-quality information. MS Conversations was lauded by Healthline for its engaging collection of personal accounts, with guest bloggers sharing […]

Read News Article

FDA Approves Zinbryta™ (Daclizumab) for Relapsing Forms of Multiple Sclerosis

Approval and Medication Overview Late on Friday, May 27, 2016, the United States Food and Drug Administration announced the approval of Zinbryta™ (daclizumab) for adults with relapsing forms of multiple sclerosis (RMS). This monoclonal antibody is self-administered subcutaneously (under-the-skin) once per month and has been shown to reduce the number of relapses as well as […]

Read News Article

MSAA Reopens MRI Access Fund

The Multiple Sclerosis Association of America (MSAA) is pleased to announce that recent funding has allowed us to reopen the MRI Access Fund on a temporary basis. The MRI program will remain open until funds are exhausted and may be suspended at any time. The MSAA MRI Access Fund assists financially challenged individuals who are […]

Read News Article